Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.03
Nov 13 • 12:05 PM ET Dollar change-0.06 Percentage change(-5.52%)
Today, 4:24 AMCibus lifts peak annual biofragrance revenue potential to about $100 million from $20 million–$40 million with direct sales, but faces cash needs before rice royalties
Index
-
Market Cap
78.71M
Enterprise Value
363.25M
Income
-96.59M
Sales
4.53M
Book/sh
-0.07
Cash/sh
0.14
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
118
IPO
Jul 20, 2017
P/E
-
Forward P/E
-
PEG
-
P/S
17.38
P/B
-
P/C
7.35
P/FCF
-
EV/EBITDA
-
EV/Sales
80.19
Quick Ratio
0.95
Current Ratio
0.95
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-1.49
EPS next Y
-0.68
EPS next Q
-0.19
EPS this Y
67.75%
EPS next Y
24.16%
EPS next 5Y
42.57%
EPS past 3/5Y
46.72% 46.96%
Sales past 3/5Y
185.12% -31.34%
EPS Y/Y TTM
84.17%
Sales Y/Y TTM
19.45%
EPS Q/Q
35.86%
Sales Q/Q
30.08%
Insider Own
38.65%
Insider Trans
0.00%
Inst Own
25.27%
Inst Trans
-7.02%
ROA
-30.58%
ROE
-431.89%
ROIC
-33.78%
Gross Margin
-6.51%
Oper. Margin
-1125.55%
Profit Margin
-2131.38%
SMA20
-18.46%
SMA50
-28.10%
SMA200
-43.32%
Trades
Shs Outstand
76.63M
Shs Float
46.89M
52W High
4.19 -75.43%
52W Low
1.07 -3.76%
Volatility
14.77% 10.83%
ATR (14)
0.13
RSI (14)
29.39
Beta
1.65
Rel Volume
1.22
Avg Volume
111.31K
Volume
60,140
Perf Week
-12.73%
Perf Month
-20.17%
Perf Quarter
-38.34%
Perf Half Y
-21.39%
Perf YTD
-40.82%
Perf Year
-17.62%
Perf 3Y
-92.47%
Perf 5Y
-99.42%
Perf 10Y
-
Prev Close
1.09
Price
1.03
Change %
-5.52%
Consensus
Buy
Avg. Price Target
$12.00
Implied Upside
+1,065.3%
Analysts3incl. previous ratings
Rating Distribution3 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 29, 2024Initiated
AAlliance Global Partners
Buy$25+2,327.7%
Jul 19, 2024Resumed
CCanaccord Genuity
Buy$22+2,036.3%
Oct 09, 2023Initiated
HH.C. Wainwright
Buy$25+2,327.7%
Jul 19, 2023Resumed
CCanaccord Genuity
Buy$30+2,813.2%
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as canola, rice, soybean, corn and wheat. The company was founded by Rory Balfour Riggs, Peter Beetham and Greg Gocal in 2001 and is headquartered in San Diego, CA.
Chief Executive OfficerMr. Craig Wichner
Ph.D.Dr. Peter R. Beetham B.Sc.
Co-FounderDr. Gregory F. Gocal Ph.D.
Co-Founder & DirectorMr. Rory Balfour Riggs M.B.A.
J.D.Mr. Jason Stokes Esq.